Logo image of OXLCN

OXFORD LANE CAPITAL CORP - OXLC 7 1/8 06/30/29 (OXLCN) Stock Fundamental Analysis

NASDAQ:OXLCN - Nasdaq - US6915438708 - Currency: USD

23.9  -0.3 (-1.24%)

Fundamental Rating

3

Taking everything into account, OXLCN scores 3 out of 10 in our fundamental rating. OXLCN was compared to 0 industry peers in the Unkown industry. OXLCN may be in some trouble as it scores bad on both profitability and health. OXLCN shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year OXLCN was profitable.
In the past year OXLCN has reported a negative cash flow from operations.
OXLCN had positive earnings in 4 of the past 5 years.
OXLCN had a negative operating cash flow in each of the past 5 years.
OXLCN Yearly Net Income VS EBIT VS OCF VS FCFOXLCN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M -600M

1.2 Ratios

Industry RankSector Rank
ROA 1.71%
ROE 2.48%
ROIC 8.05%
ROA(3y)0.77%
ROA(5y)8.45%
ROE(3y)0.32%
ROE(5y)12.57%
ROIC(3y)9.42%
ROIC(5y)8.78%
OXLCN Yearly ROA, ROE, ROICOXLCN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100

1.3 Margins

OXLCN's Profit Margin has declined in the last couple of years.
OXLCN's Operating Margin has been stable in the last couple of years.
In the last couple of years the Gross Margin of OXLCN has remained more or less at the same level.
Industry RankSector Rank
OM 62.93%
PM (TTM) 11.26%
GM 64.83%
OM growth 3Y1.54%
OM growth 5Y1.07%
PM growth 3Y-43.73%
PM growth 5YN/A
GM growth 3Y1.46%
GM growth 5Y0.91%
OXLCN Yearly Profit, Operating, Gross MarginsOXLCN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 200 -200

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, OXLCN has more shares outstanding
The number of shares outstanding for OXLCN has been increased compared to 5 years ago.
OXLCN has a better debt/assets ratio than last year.
OXLCN Yearly Shares OutstandingOXLCN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
OXLCN Yearly Total Debt VS Total AssetsOXLCN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

OXLCN has an Altman-Z score of 7.55. This indicates that OXLCN is financially healthy and has little risk of bankruptcy at the moment.
OXLCN has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 7.55
ROIC/WACCN/A
WACCN/A
OXLCN Yearly LT Debt VS Equity VS FCFOXLCN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.76 indicates that OXLCN should not have too much problems paying its short term obligations.
A Quick Ratio of 1.76 indicates that OXLCN should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.76
OXLCN Yearly Current Assets VS Current LiabilitesOXLCN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.77% over the past year.
OXLCN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.01% yearly.
OXLCN shows a strong growth in Revenue. In the last year, the Revenue has grown by 40.34%.
Measured over the past years, OXLCN shows a very strong growth in Revenue. The Revenue has been growing by 27.97% on average per year.
EPS 1Y (TTM)39.77%
EPS 3Y-30.19%
EPS 5Y1.01%
EPS Q2Q%15.91%
Revenue 1Y (TTM)40.34%
Revenue growth 3Y34.07%
Revenue growth 5Y27.97%
Sales Q2Q%-41.66%

3.2 Future

The Earnings Per Share is expected to decrease by -3.02% on average over the next years.
Based on estimates for the next years, OXLCN will show a very strong growth in Revenue. The Revenue will grow by 44.97% on average per year.
EPS Next Y5.32%
EPS Next 2Y-6.69%
EPS Next 3Y-3.02%
EPS Next 5YN/A
Revenue Next Year42.59%
Revenue Next 2Y46.74%
Revenue Next 3Y44.97%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OXLCN Yearly Revenue VS EstimatesOXLCN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
OXLCN Yearly EPS VS EstimatesOXLCN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 1.5

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 19.43, which indicates a rather expensive current valuation of OXLCN.
OXLCN is valuated rather cheaply when we compare the Price/Earnings ratio to 26.65, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 22.32 indicates a rather expensive valuation of OXLCN.
When comparing the Price/Forward Earnings ratio of OXLCN to the average of the S&P500 Index (21.27), we can say OXLCN is valued inline with the index average.
Industry RankSector Rank
PE 19.43
Fwd PE 22.32
OXLCN Price Earnings VS Forward Price EarningsOXLCN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OXLCN Per share dataOXLCN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
OXLCN's earnings are expected to decrease with -3.02% in the coming years. This may justify a cheaper valuation.
PEG (NY)3.65
PEG (5Y)19.33
EPS Next 2Y-6.69%
EPS Next 3Y-3.02%

3

5. Dividend

5.1 Amount

OXLCN has a Yearly Dividend Yield of 19.59%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.44, OXLCN pays a better dividend.
Industry RankSector Rank
Dividend Yield 19.59%

5.2 History

The dividend of OXLCN decreases each year by -8.99%.
OXLCN has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)-8.99%
Div Incr Years0
Div Non Decr Years2
OXLCN Yearly Dividends per shareOXLCN Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

OXLCN pays out 636.69% of its income as dividend. This is not a sustainable payout ratio.
OXLCN's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP636.69%
EPS Next 2Y-6.69%
EPS Next 3Y-3.02%
OXLCN Yearly Income VS Free CF VS DividendOXLCN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M -600M
OXLCN Dividend Payout.OXLCN Dividend Payout, showing the Payout Ratio.OXLCN Dividend Payout.PayoutRetained Earnings

OXFORD LANE CAPITAL CORP - OXLC 7 1/8 06/30/29

NASDAQ:OXLCN (6/23/2025, 8:00:02 PM)

23.9

-0.3 (-1.24%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-20 2025-05-20/bmo
Earnings (Next)07-24 2025-07-24
Inst Owners3.99%
Inst Owner ChangeN/A
Ins Owners3.58%
Ins Owner ChangeN/A
Market Cap10.83B
Analysts85
Price Target28.54 (19.41%)
Short Float %0%
Short Ratio0.63
Dividend
Industry RankSector Rank
Dividend Yield 19.59%
Yearly Dividend0.89
Dividend Growth(5Y)-8.99%
DP636.69%
Div Incr Years0
Div Non Decr Years2
Ex-Date05-16 2025-05-16 (0.1484375)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.36%
PT rev (3m)8.41%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-4.55%
EPS NY rev (3m)-4.55%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)3.5%
Revenue NY rev (3m)3.5%
Valuation
Industry RankSector Rank
PE 19.43
Fwd PE 22.32
P/S 25.16
P/FCF N/A
P/OCF N/A
P/B 5.54
P/tB 5.54
EV/EBITDA N/A
EPS(TTM)1.23
EY5.15%
EPS(NY)1.07
Fwd EY4.48%
FCF(TTM)-1.55
FCFYN/A
OCF(TTM)-1.55
OCFYN/A
SpS0.95
BVpS4.32
TBVpS4.32
PEG (NY)3.65
PEG (5Y)19.33
Profitability
Industry RankSector Rank
ROA 1.71%
ROE 2.48%
ROCE 10.19%
ROIC 8.05%
ROICexc 9.05%
ROICexgc 9.05%
OM 62.93%
PM (TTM) 11.26%
GM 64.83%
FCFM N/A
ROA(3y)0.77%
ROA(5y)8.45%
ROE(3y)0.32%
ROE(5y)12.57%
ROIC(3y)9.42%
ROIC(5y)8.78%
ROICexc(3y)9.92%
ROICexc(5y)9.31%
ROICexgc(3y)9.93%
ROICexgc(5y)9.32%
ROCE(3y)11.93%
ROCE(5y)11.11%
ROICexcg growth 3Y2.66%
ROICexcg growth 5Y-5.82%
ROICexc growth 3Y2.66%
ROICexc growth 5Y-5.82%
OM growth 3Y1.54%
OM growth 5Y1.07%
PM growth 3Y-43.73%
PM growth 5YN/A
GM growth 3Y1.46%
GM growth 5Y0.91%
F-Score4
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 7.9
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.76
Quick Ratio 1.76
Altman-Z 7.55
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.77%
EPS 3Y-30.19%
EPS 5Y1.01%
EPS Q2Q%15.91%
EPS Next Y5.32%
EPS Next 2Y-6.69%
EPS Next 3Y-3.02%
EPS Next 5YN/A
Revenue 1Y (TTM)40.34%
Revenue growth 3Y34.07%
Revenue growth 5Y27.97%
Sales Q2Q%-41.66%
Revenue Next Year42.59%
Revenue Next 2Y46.74%
Revenue Next 3Y44.97%
Revenue Next 5YN/A
EBIT growth 1Y45.25%
EBIT growth 3Y31.26%
EBIT growth 5Y30.02%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-468.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-468.52%
OCF growth 3YN/A
OCF growth 5YN/A